A

Auxilium Health

Biomaterial platform for infection-preventive wound care

Field Calibration Technician

Full-Time
CA$50k - CA$60k/yr
Mid
Bachelor's
Oshawa, ON, Canada
In PersonTravel to client facilities is required.
Manufacturing Quality & Test

About the job

Requirements
  • Experience with database administration.
  • Ability to multitask and work effectively in a fast-paced environment.
  • Excellent verbal communication skills and ability to explain complex analytical information to non-specialists.
  • Ability to read, understand, and comply with company policies and standard operating procedures, including safety rules and regulations.
  • A general understanding of laboratory processes is strongly recommended.
  • A valid G driver's licence and access to a vehicle are required.
  • A bachelor's degree or advanced diploma in engineering, engineering technology, instrumentation, or science, or relevant industry experience; an equivalent combination of education, training, and industry experience may be considered.
  • Knowledge of ISO/IEC 17025, ISO/IEC 9001, Good Manufacturing Practices, pharmaceutical regulations, Good Documentation Practices, data integrity principles including ALCOA+, qualification principles, temperature mapping and controlled-environment qualification standards, metrological traceability, calibration practices, applicable CSA, ANSI, ASTM, ASHRAE, and ISO/IEC standards, and accreditation and audit requirements.
Responsibilities
  • Coordinate calibration activities for controlled-temperature equipment in compliance with applicable requirements, including ISO/IEC 17025, ISO/IEC 9001, and ICH.
  • Perform calibrations and verifications on controlled-temperature equipment, including refrigerators, freezers, ultra-low freezers, incubators, stability chambers, environmental chambers, ovens, autoclaves, warehouses, storage areas, and cold-chain equipment.
  • Ensure calibrations are traceable to recognized national or international measurement standards, such as SI.
  • Prepare testing documentation, including work orders, worksheets, and laboratory reports.
  • Create and maintain standard operating procedures and controlled documents for equipment maintenance and calibration.
  • Support Installation Qualification, Operational Qualification, and Performance Qualification protocols, focusing primarily on controlled-temperature systems.
  • Conduct temperature mapping, thermal distribution, and environmental monitoring studies.
  • Support onboarding and ongoing validation of laboratory equipment, particularly where traceability expertise is required.
  • Prepare written protocols, validation reports, and risk assessments.
  • Set predefined acceptance criteria, analyze data, and evaluate compliance.
  • Assist with development and validation of monitoring systems and data acquisition systems.
  • Support investigations and documentation related to equipment failures, excursions, deviations, and non-conformances.
  • Coordinate calibration, qualification, preventative maintenance, and service activities for laboratory instrumentation and associated systems.
  • Maintain equipment files, including specifications, qualification records, calibration certificates, maintenance records, and validation documents.
  • Coordinate external service providers and vendors as required, and review vendor documentation for compliance with applicable standards and quality requirements.
  • Travel to client facilities to perform calibration, qualification, validation, and temperature mapping activities, and represent the company professionally during on-site services.
  • Communicate proactively with customers by phone, email, or in person regarding inquiries, project amendments, issues, concerns, and complaints.
  • Coordinate project timelines and testing activities with client personnel, and communicate project updates, findings, deviations, and recommendations to clients.
  • Collaborate with the Quality & Compliance Technician to plan and execute internal and client projects.
  • Ensure activities comply with applicable quality standards, accreditation requirements, and regulatory expectations.
  • Participate in internal and external audits, accreditation assessments, and client inspections.
  • Review and maintain standard operating procedures, forms, protocols, and quality documents.
  • Support corrective and preventive action investigations.
  • Follow Good Documentation Practices and maintain accurate, contemporaneous records.
  • Respond to equipment alerts after normal working hours and on weekends when required.
Desired Qualifications
  • A general understanding of laboratory processes is strongly recommended.

About the company

Auxilium Health develops biomaterials for proactive wound care that combine therapeutics and diagnostics to prevent infections. Its main product, Aux-Shield, is a skin-mimicking biomaterial that kills individual bacteria to stop biofilm formation, while Aux-Color is a diagnostic that changes color to show a wound’s healing stage. The platform's theranostic approach distinguishes it from typical wound-care products by both treating infection risk and signaling healing progress. The company aims to shift wound care from reactive to preventive, pursue FDA clearance, and work with hospitals and clinics to reduce chronic wounds and related costs through a reimbursement-based model.

Company Size

11-50

Company Stage

Seed

Total Funding

$5.4M

Headquarters

Cleveland, Ohio

Founded

2022

Get referred to Auxilium Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 14, 2026 seed closed oversubscribed, signaling investor conviction after pre-seed.
  • Headcount doubled in 2025-2026, accelerating R&D execution in Cleveland.
  • NSF, Ohio Department of Development, and strategic investors validate Auxilium's regulatory path.

What critics are saying

  • $3.4 million seed funding barely covers FDA clearance and first-in-human studies.
  • No clinical data yet; 2026 timelines slip if preclinical reproducibility weakens.
  • Stronger wound-care incumbents can copy color-change claims and squeeze reimbursement pathways.

What makes Auxilium Health unique

  • Aer mimics extracellular matrix, resisting bacterial attachment without antibiotics.
  • Auxilium combines wound repair, bone regeneration, and localized delivery in one platform.
  • Cleveland Clinic Global Innovation Center plus University of Akron licensing anchors scientific credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-15%

2 year growth

-15%
Citybiz
Jul 14th, 2026
Auxilium Health raises oversubscribed $3.4 million seed round to advance Aer biomaterial platform.

Auxilium Health raises oversubscribed $3.4 million seed round to advance Aer biomaterial platform. July 14, 2026 Auxilium Health has closed an oversubscribed $3.4 million seed financing, approximately one year after its pre-seed round, to accelerate development of its Aer(TM) biomaterial platform toward FDA clearance and first-in-human clinical studies. The financing was backed by both existing and new regional and strategic investors, more than doubling the company's previous funding and supporting continued expansion of its research and development efforts. Auxilium is developing a new class of bioaerogels designed to address one of the longstanding challenges in biomaterials: preventing bacterial colonization while promoting tissue regeneration. Rather than relying on antibiotics, the company's Aer(TM) platform is engineered to mimic the body's extracellular matrix, resisting bacterial attachment while encouraging regenerative cells to populate the material. The new capital will fund advancement of the company's lead product through regulatory development, expand its scientific team, and support additional research. Over the past year, Auxilium said it has doubled its full-time workforce, recruiting researchers and scientists to its Cleveland headquarters. "Last year, the question was whether the science was real. This year, it's how fast we can get it to patients," said Isaiah Kaiser, PhD, Founder and CEO of Auxilium Health. "We're grateful to our investors and partners who believe in the science and the team behind what we're building." Headquartered at the Cleveland Clinic's Global Innovation Center, Auxilium Health develops biomaterials for wound repair, bone regeneration, and localized therapeutic delivery. The company is also supported by the National Science Foundation, the Ohio Department of Development, and the Polymer Industry Cluster.

Vialynx Inc
Jul 14th, 2026
Auxilium Health closes oversubscribed $3.4 million seed round to advance its Aer(TM) biomaterial platform.

Auxilium Health closes oversubscribed $3.4 million seed round to advance its Aer(TM) biomaterial platform. Science · JUL 14, 2026 PR Newswire CLEVELAND, July 14, 2026 /PRNewswire/ - Auxilium Health today announced the close of an oversubscribed $3.4 million seed round, a year after closing its... CLEVELAND, July 14, 2026 /PRNewswire/ - Auxilium Health today announced the close of an oversubscribed $3.4 million seed round, a year after closing its pre-seed, to advance its Aer(TM) biomaterial platform toward FDA clearance and first-in-human studies. Backed by returning and new regional and strategic investors, the round more than doubles the company's prior raise and reflects growing conviction in both the technology and the progress behind it. For nearly four decades, biomaterials have tried to win what surgeons and scientists call the "race for the surface," the contest between a patient's healing cells and bacteria to colonize a material first, by killing bacteria after they arrive. Auxilium takes a different approach. Its Aer(TM) platform is an engineered matrix-like product that mimics the body's own extracellular matrix, built to win that race structurally by resisting bacterial attachment while welcoming regenerative cells, all without relying on antibiotics. The new capital will advance the company's lead product toward FDA clearance and into first-in-human use while deepening the team and the research behind it. Over the last year, Auxilium's full-time team has doubled, attracting top researchers and scientists to relocate to Cleveland to join the mission. "Last year, the question was whether the science was real. This year, it's how fast we can get it to patients," said Isaiah Kaiser, PhD, Founder and CEO of Auxilium Health. "We're grateful to our investors and partners who believe in the science and the team behind what we're building. Their confidence lets us move with the urgency this problem deserves." About Auxilium Health Auxilium Health develops a new class of bioaerogels that reduce the risk of bacterial colonization and guide tissue regeneration. Its Aer(TM) platform spans wound repair, bone regeneration, and localized delivery, with a lead product advancing toward FDA clearance and clinical studies. Headquartered at the Cleveland Clinic's Global Innovation Center, the company is supported by the National Science Foundation, the Ohio Department of Development, and the Polymer Industry Cluster. Regeneration begins at the surface. Media Contact Lindsey Dinneen Director of Marketing & Engagement Project Medtech [email protected] SOURCE Auxilium Health Published by News Desk · WeeklyReviewer The WeeklyReviewer news desk monitors breaking developments around the clock - sourcing, verifying, and publishing real-time industry news across business, technology, politics, science, sports, and world affairs. Every story that comes through the Live Wire is reviewed for accuracy before publication, keeping our readers ahead of the curve without the noise.

PR Newswire
Jul 14th, 2026
Auxilium Health closes oversubscribed $3.4M seed round to advance Aer biomaterial platform

Cleveland-based Auxilium Health has closed an oversubscribed $3.4 million seed round to advance its Aer™ biomaterial platform towards FDA clearance and first-in-human studies. The funding, raised one year after the company's pre-seed round, more than doubles Auxilium's previous raise and comes from returning and new regional and strategic investors. Auxilium's Aer™ platform is an engineered matrix that mimics the body's extracellular matrix, designed to resist bacterial attachment whilst welcoming regenerative cells without using antibiotics. The company's full-time team has doubled over the past year, attracting researchers and scientists to Cleveland. Headquartered at the Cleveland Clinic's Global Innovation Centre, Auxilium is supported by the National Science Foundation, the Ohio Department of Development, and the Polymer Industry Cluster.

FinSMEs
Apr 9th, 2025
Auxilium Health Closes $1.5M in Funding; Secures Additional $275K Grant from the National Science Foundation

Auxilium Health closes $1.5M in funding; secures additional $275K grant from the National Science Foundation.

Morningstar
Apr 9th, 2025
Auxilium Health Raises $1.5M Funding

Auxilium Health announced the closing of an oversubscribed $1.5 million pre-seed funding round, surpassing its $1.2 million target, led by regional investors in Ohio. Additionally, the company secured a $275k grant from the National Science Foundation, highlighting national validation of their biomaterial technology. CEO Isaiah Kaiser expressed gratitude for the support, emphasizing the funding's role in advancing their biomaterial platform for skin tissue regeneration and infection management.